Low-Dose Low-Molecular-Weight Heparin for Thromboprophylaxis During Pregnancy.

Per this study summary, in women with a history of venous thromboembolism, weight-adjusted intermediate-dose low-molecular-weight heparin across the combined antepartum and postpartum periods did not reduce recurrence compared with fixed low-dose low-molecular-weight heparin, with the authors noting further study is needed on whether intermediate dosing helps specifically postpartum. For hirudotherapy this serves only as background on the wider anticoagulation/thromboprophylaxis field, in which heparins are the established injectable comparators; leech-derived agents act on thrombin directly rather than through the heparin-antithrombin pathway studied here. Honest caveat: the page carries only a brief study-summary abstract rather than full methods, so sample size and effect estimates are not stated; it concerns subcutaneous heparin in pregnancy and contains no leech or hirudotherapy content, so its relevance is purely contextual.